Radiation therapy poses a risk of radiation-induced cardiomyopathy (RIC) as the heart is exposed during treatment of chest malignancies.Advanced radiation therapy techniques like IMRT and proton therapy aim to reduce cardiac exposure and enhance patient safety.Additional protective measures such as MLC and patient positioning help minimize heart radiation dose during therapy.Post-therapy cardiac screening is essential for early detection of cardiovascular issues and timely intervention.Oxidative stress induced by radiation plays a role in RIC; antioxidant interventions like statins are explored for cardioprotection.Herbal supplements with antioxidant properties are being studied as potential defenses against radiation-induced oxidative damage.Researchers emphasize proactive cardiac evaluation and prompt treatment initiation to improve patient outcomes post-therapy.Innovative management strategies are crucial in addressing the evolving landscape of cancer treatment and RIC prevention.Collaboration among oncologists, cardiologists, and researchers is vital for understanding and managing RIC effectively.Emphasis on systemic monitoring and timely response to cardiovascular issues in cancer survivors can shape the future of radiotherapy.